Journal article
Durable and controlled depletion of neutrophils in mice.
-
Boivin G
Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
-
Faget J
Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
-
Ancey PB
Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
-
Gkasti A
Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
-
Mussard J
University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373, Lyon, France.
-
Engblom C
Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA, 02114, USA.
-
Pfirschke C
Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA, 02114, USA.
-
Contat C
Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
-
Pascual J
Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
-
Vazquez J
Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland.
-
Bendriss-Vermare N
University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373, Lyon, France.
-
Caux C
University of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373, Lyon, France.
-
Vozenin MC
Laboratory of Radiation Oncology, Department of Radiation Oncology, Department of Oncology, CHUV, Lausanne University Hospital and University of Lausanne, CH-1011, Lausanne, Switzerland.
-
Pittet MJ
Center for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, MA, 02114, USA.
-
Gunzer M
Institute for Experimental Immunology and Imaging, University Hospital, University Duisburg-Essen, Essen, Germany.
-
Meylan E
Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015, Lausanne, Switzerland. etienne.meylan@epfl.ch.
Show more…
Published in:
- Nature communications. - 2020
English
Neutrophils are an essential part of the innate immune system. To study their importance, experimental studies often aim to deplete these cells, generally by injecting anti-Ly6G or anti-Gr1 antibodies. However, these approaches are only partially effective, transient or lack specificity. Here we report that neutrophils remaining after anti-Ly6G treatment are newly derived from the bone marrow, instead of depletion escapees. Mechanistically, newly generated, circulating neutrophils have lower Ly6G membrane expression, and consequently reduced targets for anti-Ly6G-mediated depletion. To overcome this limitation, we develop a double antibody-based depletion strategy that enhances neutrophil elimination by anti-Ly6G treatment. This approach achieves specific, durable and controlled reduction of neutrophils in vivo, and may be suitable for studying neutrophil function in experimental models.
-
Language
-
-
Open access status
-
gold
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/278275
Statistics
Document views: 41
File downloads: